-+ 0.00%
-+ 0.00%
-+ 0.00%

Traws Pharma Q3 EPS $(0.18) Beats $(0.20) Estimate

Benzinga·11/16/2026 21:52:45
Listen to the news
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 47.06 percent increase over losses of $(0.34) per share from the same period last year.